4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-20-000019
COO and SVP, R&D acquired 5,128 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Johnston Lloyd P. · COO and SVP, R&D
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-01-16 | Exercise or conversion : show line 1 in the form | +5,128 | $0.47 | $2,410 | 16,734 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-01-16 | Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) | −5,128 | $0.47 | 2020-01-19 | 5,128 | 0 | D |
Loading xslF345X03/wf-form4_157964528662973.xml…